Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Point-of-Care Ultrasound as a Component of Preparticipation Screening of Athletes: A Systematic Review.

Cassels M, Moulson N, Regan J, MacDonald M, Isserow S, Johri AM, McKinney J.

J Ultrasound Med. 2019 May 12. doi: 10.1002/jum.15021. [Epub ahead of print] Review.

PMID:
31081230
2.

Automated External Defibrillator and Emergency Action Plan Preparedness Amongst Canadian University Athletics.

Reagan J, Moulson N, Velghe J, Cater C, Taylor T, Isserow S, McKinney J.

Can J Cardiol. 2019 Jan;35(1):92-95. doi: 10.1016/j.cjca.2018.10.012. Epub 2018 Oct 26.

PMID:
30595187
3.

Defining Athletes and Exercisers.

McKinney J, Velghe J, Fee J, Isserow S, Drezner JA.

Am J Cardiol. 2019 Feb 1;123(3):532-535. doi: 10.1016/j.amjcard.2018.11.001. Epub 2018 Nov 6.

PMID:
30503799
4.

Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.

Traboulsee AL, Machan L, Girard JM, Raymond J, Vosoughi R, Hardy BW, Emond F, Gariepy JL, Bone JN, Siskin G, Klass D, Isserow S, Illes J, Sadovnick AD, Li DK.

Neurology. 2018 Oct 30;91(18):e1660-e1668. doi: 10.1212/WNL.0000000000006423. Epub 2018 Sep 28.

5.

Perspectives on pre-participation cardiovascular screening in young competitive athletes: U SPORTS.

Cater C, MacDonald M, Lithwick D, Sidhu K, Isserow S, McKinney J.

Phys Sportsmed. 2018 Nov;46(4):509-514. doi: 10.1080/00913847.2018.1516107. Epub 2018 Sep 8.

PMID:
30148661
6.

Assessment of cardiovascular risk and preparticipation screening protocols in masters athletes: the Masters Athlete Screening Study (MASS): a cross-sectional study.

Morrison BN, McKinney J, Isserow S, Lithwick D, Taunton J, Nazzari H, De Souza AM, Heilbron B, Cater C, MacDonald M, Hives BA, Warburton DER.

BMJ Open Sport Exerc Med. 2018 Aug 9;4(1):e000370. doi: 10.1136/bmjsem-2018-000370. eCollection 2018.

7.

Cardiac Arrest during Competitive Sports.

McKinney J, Isserow S, Krahn A.

N Engl J Med. 2018 Apr 12;378(15):1462-3. doi: 10.1056/NEJMc1802593. No abstract available.

PMID:
29648425
8.

Detecting Underlying Cardiovascular Disease in Young Competitive Athletes.

McKinney J, Lithwick DJ, Morrison BN, Nazzari H, Luong M, Fordyce CB, Taunton J, Krahn AD, Heilbron B, Isserow S.

Can J Cardiol. 2017 Jan;33(1):155-161. doi: 10.1016/j.cjca.2016.06.007. Epub 2016 Jun 23.

PMID:
27692657
9.

Prevalence and Associated Clinical Characteristics of Exercise-Induced ST-Segment Elevation in Lead aVR.

McKinney J, Pitcher I, Fordyce CB, Yousefi M, Yeo TJ, Ignaszewski A, Isserow S, Chan S, Ramanathan K, Taylor CM.

PLoS One. 2016 Jul 28;11(7):e0160185. doi: 10.1371/journal.pone.0160185. eCollection 2016.

10.

The First Dedicated Cardiac Rehabilitation Program for Patients With Spontaneous Coronary Artery Dissection: Description and Initial Results.

Chou AY, Prakash R, Rajala J, Birnie T, Isserow S, Taylor CM, Ignaszewski A, Chan S, Starovoytov A, Saw J.

Can J Cardiol. 2016 Apr;32(4):554-60. doi: 10.1016/j.cjca.2016.01.009. Epub 2016 Jan 18.

PMID:
26923234
11.

Cardiology patient page. Spontaneous coronary artery dissection (SCAD).

Saw J, Sedlak T, Ganesh SK, Isserow S, Mancini GB.

Circulation. 2015 Jan 6;131(1):e3-5. doi: 10.1161/CIRCULATIONAHA.114.010773. No abstract available.

PMID:
25561479
12.

Macrotroponin causing elevation in cardiac troponin I.

Wong SL, Isserow S, Pudek M.

Can J Cardiol. 2014 Aug;30(8):956.e5-6. doi: 10.1016/j.cjca.2014.03.037. Epub 2014 Apr 2.

PMID:
24999169
13.

Characterization of aerobically fit individuals with cardiovascular disease.

Lesser IA, Farias-Godoy A, Isserow S, Myers J, Lear SA.

Eur J Sport Sci. 2014;14(7):737-42. doi: 10.1080/17461391.2013.876103. Epub 2014 Jan 16.

PMID:
24433153
14.

Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS.

Kingwell E, Koch M, Leung B, Isserow S, Geddes J, Rieckmann P, Tremlett H.

Neurology. 2010 Jun 1;74(22):1822-6. doi: 10.1212/WNL.0b013e3181e0f7e6. Epub 2010 Apr 28.

15.

Sex differences in left ventricular function and beta-receptor responsiveness following prolonged strenuous exercise.

Scott JM, Esch BT, Haykowsky MJ, Isserow S, Koehle MS, Hughes BG, Zbogar D, Bredin SS, McKenzie DC, Warburton DE.

J Appl Physiol (1985). 2007 Feb;102(2):681-7. Epub 2006 Nov 2.

17.

Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.

Schellenberg RR, Isserow SH.

N Engl J Med. 2001 Dec 20;345(25):1856. No abstract available.

PMID:
11752370
18.

Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.

Huckell VF, Bernstein V, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A.

Can J Cardiol. 1997 Feb;13(2):173-82. Review.

PMID:
9070169
19.

Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical data.

Huckell VF, Bernstein V, Cairns JA, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A.

Can J Cardiol. 1997 Feb;13(2):161-9. Review.

PMID:
9070168

Supplemental Content

Loading ...
Support Center